PPT-Ovarian cancer update Kentucky cancer Registry

982016 Erica Takimoto DO FACOOG Gynecologic Oncology Insidious onset Bloating Increased abdominal girth Pelvic mass on CTUSMRI No good screening test CA 125 OVA1 Clinical acumen is paramount . St. Vincent’s Clay. NEFHIMA. September 10, 2015. Objectives. Discuss changes effecting cancer registry operations. Role with implementation of Survivorship Program. Discuss conversion from ICD 9 to ICD10 and impact on Cancer Registry Operations. Linda Cope, CTR. HCC Registry . Coordinator. copel@musc.edu. Commission on Cancer . DHEC’s SC Central Cancer Registry. CoC facilities collect data in standardized codes and report to NCDB. . SC Law: CHAPTER 35; . Lisa McCluskey, MD. Gynecologic Oncologist. June 16, 2015. Compass Oncology . in partnership with . Ovarian . Cancer Alliance of Oregon & SW . Washington. What. is Ovarian Cancer. ?. The most common type of Ovarian Cancer that starts from . Diagnostic work-up. Treatment. The most commonly occurring gynecologic cancer is:. Cervical. Endometrial. Ovarian. Vulvar. The gynecologic cancer with the highest death rate is:. Cervical. Endometrial. Siew. . wei. . wong. Oncology registrar. Epidemiology. 225000 new incidence annually worldwide. Incidence stable since 1970s. 1600 new cases in Australia in 2010. Median age at diagnosis 63. Fourth commonest cause of cancer death in women in developed countries. Lisa McCluskey, MD. Gynecologic Oncologist. June 16, 2015. Compass Oncology . in partnership with . Ovarian . Cancer Alliance of Oregon & SW . Washington. What. is Ovarian Cancer. ?. The most common type of Ovarian Cancer that starts from . th. most incident and lethal cancer. New cases: 225,000 annually. Deaths: 140,000 annually. *Almost 75% of cases present with advanced stage .. *Risk of relapse of advanced stage disease is as high as 70%. Wilhelmina Ross, . PA, MPH, CTR - Westat. Jeannette Jackson-Thompson. , MSPH, PHD n- . Missouri Cancer Registry and Research Center . Diane . Ng, MPH, . Westat . Maricarmen . Traverso-Ortiz, MPH, CTR - . Impactful Data from a Highly Burdened Population. Principal Investigator. B Mark Evers, MD. Key Personnel. Eric B. Durbin, DrPH, MS, Project Lead. Jay Christian, PhD. Erin Haynes, PhD. John L. . Villano. Christopher Morse, MD. Fellow, Gynecologic oncology. UW MEDICINE. CONFIDENTIAL – DO NOT DISTRIBUTE. Overview. Introduction to ovarian cancer. Diagnosis and treatment. Surgery and chemotherapy. Surveillance. 2/22/2007 p lus/ rint/enc Page 2of 3 2/22/2007 p lus/ rint/enc The information provided should not be used during any medical emergency or for the diagnosis or treatment of any medical condilicensed p Genetics of ovarian cancer. 49F. Underwent risk-reduction surgery. Total hysterectomy and bilateral . salpingo. -oophorectomy. Significant family history . Sister passed away in her 40s due to breast cancer. by. Nancy A. Rice, Department of Biology, Western Kentucky University, and. Bruno Borsari, Biology Department, Winona State University. 1. Abby is Sick:. Review of the Story So Far…. Abby has been having abdominal pain.. Stephanie M. Hill, MPH, CTR. Associate Director, NAACCR. Objectives. Discuss the justification for forming a national registry of childhood cancers. Detail the NCCR infrastructure. Provide an update on the current status of the NCCR.